Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood

Jung K, Laube C, Lein M, Lichtinghagen R, Tschesche H, Schnorr D, Loening SA (1998)
CLINICAL CHEMISTRY 44(5): 1060-1062.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Jung K, Laube C, Lein M, et al. Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. CLINICAL CHEMISTRY. 1998;44(5):1060-1062.
Jung, K., Laube, C., Lein, M., Lichtinghagen, R., Tschesche, H., Schnorr, D., & Loening, S. A. (1998). Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. CLINICAL CHEMISTRY, 44(5), 1060-1062.
Jung, K., Laube, C., Lein, M., Lichtinghagen, R., Tschesche, H., Schnorr, D., and Loening, S. A. (1998). Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. CLINICAL CHEMISTRY 44, 1060-1062.
Jung, K., et al., 1998. Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. CLINICAL CHEMISTRY, 44(5), p 1060-1062.
K. Jung, et al., “Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood”, CLINICAL CHEMISTRY, vol. 44, 1998, pp. 1060-1062.
Jung, K., Laube, C., Lein, M., Lichtinghagen, R., Tschesche, H., Schnorr, D., Loening, S.A.: Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. CLINICAL CHEMISTRY. 44, 1060-1062 (1998).
Jung, K, Laube, C, Lein, M, Lichtinghagen, R, Tschesche, Harald, Schnorr, D, and Loening, SA. “Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood”. CLINICAL CHEMISTRY 44.5 (1998): 1060-1062.
This data publication is cited in the following publications:
This publication cites the following data publications:

43 Citations in Europe PMC

Data provided by Europe PubMed Central.

Reappraisal of quantitative gel zymography for matrix metalloproteinases.
Prescimone T, Tognotti D, Caselli C, Cabiati M, D'Amico A, Del Ry S, Giannessi D., J. Clin. Lab. Anal. 28(5), 2014
PMID: 24648291
Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9.
Lee R, Adlam D, Antoniades C, Digby JE, Kharbanda RK, Choudhury RP, Channon KM., Int. J. Cardiol. 163(2), 2013
PMID: 22805545
Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal.
Colotti C, Angeli V, Del Ry S, Maltinti M, Vittorini S, Giannessi D., Clin. Chem. Lab. Med. 45(10), 2007
PMID: 17727309
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Zucker S, Wang M, Sparano JA, Gradishar WJ, Ingle JN, Davidson NE; Eastern Cooperative Oncology Group., Clin. Breast Cancer 6(6), 2006
PMID: 16595036
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
Gerlach RF, Tanus-Santos JE., Clin Neurol Neurosurg 108(6), 2006
PMID: 16413675
Preanalytical conditions and circulating matrix metalloproteinases.
Verspaget HW, Kuyvenhoven JP, van Hoek B., Transplantation 79(6), 2005
PMID: 15785393
Matrix metalloproteinase-2 in blood does not indicate the progression of prostate cancer.
Jung K, Laube C, Lein M, Turk I, Lichtinghagen R, Rudolph B, Schnorr D, Loening SA., Int. J. Cancer 78(3), 1998
PMID: 9766579

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 9590387
PubMed | Europe PMC

Search this title in

Google Scholar